Results 161 to 170 of about 78,778 (305)

CD38 inhibition increases neuronal survival and reduces α-synuclein <i>in vitro</i>, elevates brain NAD<sup>+</sup>, and reduces motor deficits in a Parkinson's disease model. [PDF]

open access: yesFront Pharmacol
Harvey JRM   +16 more
europepmc   +1 more source

Patient and Healthcare Provider Satisfaction With Subcutaneous Versus Intravenous Administration of Daratumumab in Combination With Lenalidomide and Dexamethasone as First‐Line Treatment in Patients With Newly Diagnosed Non‐Transplant Eligible Multiple Myeloma: Final Results of the MYLENE Study

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Objectives The MYLENE non‐interventional study (NIS) aimed to close the gap in real‐world data on the experience and satisfaction with subcutaneous (sc) and intravenous (iv) daratumumab application in patients with newly diagnosed non‐transplant eligible multiple myeloma in Germany.
Eyck von der Heyde   +9 more
wiley   +1 more source

BCMA Targeted Therapies and Their Impact on Outcomes in Relapsed or Refractory Multiple Myeloma: Results From the French EMMY Cohort

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Objectives B‐cell maturation antigen (BCMA)‐targeted therapies have recently transformed the management of relapsed or refractory multiple myeloma (RRMM). This study aimed to evaluate their implementation and real‐world impact within EMMY, a French longitudinal cohort. Methods Patients initiating a fourth or later line of therapy (L4+) between
Titouan Cazaubiel   +24 more
wiley   +1 more source

CD39, CD73, and CD38 track tumor burden and reveal immune remodeling during mogamulizumab therapy in Sézary syndrome. [PDF]

open access: yesJ Immunother Cancer
Marchisio S   +13 more
europepmc   +1 more source

Modulation of CD38 expression in human longevity: A flow cytometric study

open access: yes, 2006
The dynamics of CD38 expression innewborns and young healthy donors hasbeen widely investigated for many years.However, little is known about the modulationof this marker during humanageing.
TROIANO, Leonarda   +8 more
core  

CD38 enzymatic activity regulates LT-HSC exit from quiescence.

open access: yes
(A) Single CD38- and CD38+ LT-HSCs were sorted and cultured in liquid media with or without 78c, a CD38 inhibitor. (B) Frequency of LT-HSCs that had completed the first division during incubation time is presented (3 independent experiments).
Anupam Sinha (1974100)   +19 more
core   +1 more source

T‐Cell Response After SARS‐CoV‐2 Vaccination in Patients With Hematological Malignancy

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Patients with hematologic malignancies (HM) often mount poor humoral responses to SARS‐CoV‐2 vaccination due to their immunocompromised status. Protection against severe COVID‐19 is strongly related to cellular immunity, yet vaccine‐induced T‐cell responses remain incompletely characterized.
L. S. Boerenkamp   +7 more
wiley   +1 more source

Cutaneous involvement by myeloid leukaemias: challenging cases with important implications

open access: yesHistopathology, EarlyView.
Myeloid leukaemias and precursors involving the skin are often challenging to diagnose with varied and overlapping clinical and histopathologic features. Nonetheless, they are critical for pathologists to recognize and accurately classify. This review discusses the clinical, histopathological and genetic features of myelodysplasia cutis (A) and ...
Alexandra C. Hristov
wiley   +1 more source

NAD+ as a metabolic immune checkpoint in cancer. [PDF]

open access: yesCancer Metastasis Rev
Izadpanah R, Alt EU.
europepmc   +1 more source

Comparison of intestinal histopathological changes following teclistamab, BCMA‐directed CAR T, CD19‐directed CAR T and rituximab therapies

open access: yesHistopathology, EarlyView.
This is a retrospective review of intestinal tract biopsies from patients treated with various cellular immunotherapies (BCMA and CD19‐directed CAR T, teclistamab and rituximab therapies). We found distinct but overlapping histologic patterns across treatment groups, with lamina propria plasma cell depletion, crypt apoptotic bodies and active ...
Olivia J Leung   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy